Targeting MEK for the Treatment of Non Small-Cell Lung Cancer

le Goldman, Jonathan W., Garon, Edward B.
Foilsithe 2012

Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management

le Goldman, Jonathan W., Mendenhall, Melody A., Rettinger, Sarah R.
Foilsithe in Oncologist (2016)

KEYNOTE-021 cohorts D and H suggest modest benefit in combining ipilimumab with pembrolizumab in second-line or later advanced non-small cell lung cancer treatment

le Cummings, Amy Lauren, Santoso, Kate M., Goldman, Jonathan W.
Foilsithe in Transl Lung Cancer Res (2019)

Extended Progression-Free Survival in Two Patients With Alveolar Soft Part Sarcoma Exposed to Tivantinib

le Goldberg, John M., Gavcovich, Tara, Saigal, Gaurav, Goldman, Jonathan W., Rosen, Lee S.
Foilsithe in J Clin Oncol (2014)

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

le Shen, John, Chang, Jason, Mendenhall, Melody, Cherry, Grace, Goldman, Jonathan W., Kulkarni, Rajan P.
Foilsithe in Ther Adv Med Oncol (2018)

PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin – case report

le Goldman, Jonathan W., Abdalla, Basmah, Mendenhall, Melody A., Sisk, Anthony, Hunt, Jaime, Danovitch, Gabriel M., Lum, Erik L.
Foilsithe in BMC Nephrol (2018)

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

le Shaverdian, Narek, Lisberg, Aaron E, Bornazyan, Krikor, Veruttipong, Darlene, Goldman, Jonathan W, Formenti, Silvia C, Garon, Edward B, Lee, Percy
Foilsithe in Lancet Oncol (2017)

Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung C...

le Gaut, Daria, Sim, Myung Shin, Yue, Yuguang, Wolf, Brian R., Abarca, Phillip A., Carroll, James M., Goldman, Jonathan W., Garon, Edward B.
Foilsithe in Clin Lung Cancer (2017)

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

le Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Foilsithe in Cancer Chemother Pharmacol (2015)

Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors

le Falchook, Gerald S., Zhou, Xiaofei, Venkatakrishnan, Karthik, Kurzrock, Razelle, Mahalingam, Devalingam, Goldman, Jonathan W., Jung, JungAh, Ullmann, Claudio Dansky, Milch, Catherine, Rosen, Lee S., Sarantopoulos, John
Foilsithe in Drugs R D (2015)

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

le Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Foilsithe in Cancer Chemother Pharmacol (2015)

Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Ca...

le Goldman, Jonathan W., Waterhouse, David M., George, Ben, O'Dwyer, Peter J., Bhore, Rafia, Banerjee, Sibabrata, Lyons, Larry, Louis, Chrystal U., Ong, Teng Jin, Kelly, Karen
Foilsithe in Front Oncol (2019)

Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer

le Dhar, Manjima, Wong, Jessica, Che, James, Matsumoto, Melissa, Grogan, Tristan, Elashoff, David, Garon, Edward B., Goldman, Jonathan W., Sollier Christen, Elodie, Di Carlo, Dino, Kulkarni, Rajan P.
Foilsithe in Sci Rep (2018)

A longitudinal investigation of internalized stigma, constrained disclosure, and quality of life across 12 weeks in lung cancer patients on active oncologic treatment

le Williamson, Timothy J., Choi, Alyssa K., Kim, Julie C., Garon, Edward B., Shapiro, Jenessa R., Irwin, Michael R., Goldman, Jonathan W., Bornyazan, Krikor, Carroll, James M., Stanton, Annette L.
Foilsithe in J Thorac Oncol (2018)

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid ma...

le Goldman, Jonathan W, Raju, Robert N, Gordon, Gregory A, El-Hariry, Iman, Teofilivici, Florentina, Vukovic, Vojo M, Bradley, Robert, Karol, Michael D, Chen, Yu, Guo, Wei, Inoue, Takayo, Rosen, Lee S
Foilsithe 2013

Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand–1 Expression for Immunotherapy in Non–Small Cell Lung Cancer

le Tsai, Emily B., Pomykala, Kelsey, Ruchalski, Kathleen, Genshaft, Scott, Abtin, Fereidoun, Gutierrez, Antonio, Kim, Hyun J., Li, Alice, Adame, Carlos, Jalalian, Ashkan, Wolf, Brian, Garon, Edward B., Goldman, Jonathan W., Suh, Robert
Foilsithe in Radiology (2018)

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors

le Rosen, Lee S., LoRusso, Patricia, Ma, Wen Wee, Goldman, Jonathan W., Weise, Amy, Colevas, A. Dimitrios, Adjei, Alex, Yazji, Salim, Shen, Angela, Johnston, Stuart, Hsieh, Hsin-Ju, Chan, Iris T., Sikic, Branimir I.
Foilsithe in Invest New Drugs (2016)

High efficiency vortex trapping of circulating tumor cells

le Dhar, Manjima, Wong, Jessica, Karimi, Armin, Che, James, Renier, Corinne, Matsumoto, Melissa, Triboulet, Melanie, Garon, Edward B., Goldman, Jonathan W., Rettig, Matthew B., Jeffrey, Stefanie S., Kulkarni, Rajan P., Sollier, Elodie, Di Carlo, Dino
Foilsithe in Biomicrofluidics (2015)

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

le Goldman, Jonathan W., Rosen, Lee S., Tolcher, Anthony W., Papadopoulos, Kyriakos, Beeram, Muralidhar, Shi, Peipei, Pitou, Celine, Bell, Robert, Kulanthaivel, Palaniappan, Zhang, Xuekui, Fink, Aaron, Chan, Edward M., Shahir, Ashwin, Farrington, Daphne, Patnaik, Amita
Foilsithe in Invest New Drugs (2017)

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

le Vadhan-Raj, Saroj, Abonour, Rafat, Goldman, Jonathan W., Smith, David A., Slapak, Christopher A., Ilaria, Robert L., Tiu, Ramon V., Wang, Xuejing, Callies, Sophie, Cox, Joanne, Tuttle, Jay L., Lau, Yiu-Keung, Roeland, Eric J.
Foilsithe in J Hematol Oncol (2017)